Seven Eight Capital’s Precigen PGEN Stock Holding History

Seven Eight Capital’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-31,913	Closed	-$769K	–	641
2016 Q4	$769K	Buy	+31,913	New	+$888K	0.15%	225
2016 Q2	–	Sell	-1,767	Closed	-$59K	–	639
2016 Q1	$59K	Sell	1,767 -14,276	-89%	-$449K	0.03%	431
2015 Q4	$479K	Buy	+16,043	New	+$541K	0.33%	105

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Seven Eight Capital's PGEN Position: Q1 2017 in Review

Seven Eight Capital sold out of Precigen (PGEN) in Q1 2017, closing a stake of 31,913 shares — an estimated $769K sold.

Seven Eight Capital first reported a position in PGEN in Q4 2015 and held it in 3 quarters. The position peaked at $769K in Q4 2016. 154 funds tracked by Wall St. Rank hold PGEN as of Q1 2017.

Seven Eight Capital reported no remaining Precigen position as of Q1 2017 after selling out during the quarter.
Seven Eight Capital sold 31,913 Precigen shares in Q1 2017, an estimated $769K.
Seven Eight Capital first reported a position in Precigen in Q4 2015 and held it in 3 quarters.
Seven Eight Capital's Precigen position peaked at $769K in Q4 2016.
154 funds tracked by Wall St. Rank held Precigen as of Q1 2017.

Based on Seven Eight Capital's 13F filing for Q1 2017, filed 15 May 2017.